Hidetsugu Fujigaki

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 4

Top Topics

Respiratory Syndrome Coronavirus

Pluripotent Stem Cells

Top Venues

Molecular cancer therapeutics

Microbiology spectrum

Annals of clinical biochemistry

This page only lists publications with an associated author ORCID identifier.

Publications

Hidekazu Ishida, Hiroki Nagasawa, Yasuko Yamamoto, Hidetsugu Fujigaki, Hiroki Doi, Midori Saito, Yuya Ishihara, Takashi Fujita, Mariko Ishida, Yohei Kato, Ryosuke Kikuchi, Hidetoshi Matsunami, Masao Takemura, Hiroyasu Ito, Kuniaki Saito
Dataset dependency of low-density lipoprotein-cholesterol estimation by machine learning. Annals of clinical biochemistry (2023)
Nao Sukeda, Hidetsugu Fujigaki, Tatsuya Ando, Honomi Ando, Yasuko Yamamoto, Kuniaki Saito
Identification of 2',4',6'-trihydroxyacetophenone as promising cysteine conjugate beta-lyase inhibitor for preventing cisplatin-induced nephrotoxicity. Molecular cancer therapeutics (2023)
Nao Sukeda, Hidetsugu Fujigaki, Tatsuya Ando, Honomi Ando, Yasuko Yamamoto, Kuniaki Saito
Identification of 2',4',6'-Trihydroxyacetophenone as Promising Cysteine Conjugate Beta-Lyase Inhibitor for Preventing Cisplatin-Induced Nephrotoxicity. Molecular cancer therapeutics (2023)
Hidetsugu Fujigaki, Yasuko Yamamoto, Takenao Koseki, Sumi Banno, Tatsuya Ando, Hiroyasu Ito, Takashi Fujita, Hiroyuki Naruse, Tadayoshi Hata, Saya Moriyama, Yoshimasa Takahashi, Tadaki Suzuki, Takahiro Murakami, Yukihiro Yoshida, Yo Yagura, Takayoshi Oyamada, Masao Takemura, Masashi Kondo, Mitsunaga Iwata, Kuniaki Saito
Antibody Responses to BNT162b2 Vaccination in Japan: Monitoring Vaccine Efficacy by Measuring IgG Antibodies against the Receptor-Binding Domain of SARS-CoV-2. Microbiology spectrum 10 (1) (2022)